Association of clinical androgen excess with radial artery intima media thickness in women with polycystic ovary syndrome

References

• Carmina E, Lobo R. Polycystic ovary syndrome: arguably the most common endocrinopathy is associated with morbidity in women. J Clin Endocrinol Metab 1999;84:1897–9
   PubMed Web of Science ®Google Scholar
• Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG 2006;113:1148–59
   PubMed Web of Science ®Google Scholar
• Orio Jr F, Palomba S, Spinelli L, et al. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. J Clin Endocrinol Metab 2004;89:3696–701
   PubMed Web of Science ®Google Scholar
• Kelly CJ, Speirs A, Gould GW, et al. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:742–6
   PubMed Web of Science ®Google Scholar
• Wenner MM, Taylor HS, Stachenfeld N. ET-B receptor contribution to peripheral microvascular functions in women with polycystic ovary syndrome. J Physiol 2011;589:4671–9
   PubMedGoogle Scholar
• Tarkun I, Arslan BC, Cantürk Z, et al. Endothelialdysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. J Clin Endocrinol Metab 2004;89:5592–6
   PubMed Web of Science ®Google Scholar
• Beckman JA, Goldfine AB, Dunaif A, et al. Endothelial function varies according to insulin resistance disease type. Diabetes Care 2007;30:1226–32
   PubMedGoogle Scholar
• Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome and type 2 diabetes. Fertil Steril 2002;77:1095–105
   PubMed Web of Science ®Google Scholar
• Luque-Ramirez M, Mendieta-Azcona C, Alvarez-Blasco F, et al. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome (PCOS). Hum Reprod 2007;22:3197–203
   PubMed Web of Science ®Google Scholar
• Ruengsakulrach P, Sinclair R, Komeda M, et al. Comparative histopathology of radial artery versus internal thoracic artery and risk factors for development of intimal hyperplasia and atherosclerosis. Circulation 1999;100:139–44
   Google Scholar
• Guleria AK, Syal SK, Kapoor A, et al. Cardiovascular disease risk in young Indian women with polycystic ovary syndrome. Gynecol Endocrinol 2014;30:26–9
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7
   PubMed Web of Science ®Google Scholar
• Wild RA, Vesely S, Beebe L, et al. FerrimanGallwey self scoring. I: performance assessment in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:4112–14
   PubMed Web of Science ®Google Scholar
• Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004;59:141–54
   PubMed Web of Science ®Google Scholar
• Morley JE, Patrick P, Perry HM 3rd. Evaluation of assays available to measure free testosterone. Metabolism 2002;5:554–9
   Google Scholar
• Lemarie CA, Tharaux PL, Lehoux S. Extracellular matrix alterations in hypertensive vascular remodeling. J Mol Cell Cardiol 2010;48:433–9
   PubMed Web of Science ®Google Scholar
• Tschakovsky ME, Pyke KE. Counterpoint: Flow-mediated dilation does not reflect nitric oxide-mediated endothelial function. J Appl Physiol 2005;99:1235–8
   PubMed Web of Science ®Google Scholar
• Dahlgren E, Janson PO, Johansson S, et al. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective study of women. Acta Obstet Gynecol Scand 1992;71:599–604
   PubMed Web of Science ®Google Scholar
• Mather KJ, Verma S, Corenblum B, Anderson TJ. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2000;85:1851–6
   PubMed Web of Science ®Google Scholar
• Barcellos CR, Lage SH, Rocha MP, et al. Polycystic ovary syndrome and obesity do not affect vascular parameters related to early atherosclerosis in young women without glucose metabolism disturbances, arterial hypertension and severe abnormalities of lipid profile. Gynecol Endocrinol 2013;29:370–4
   PubMed Web of Science ®Google Scholar
• Kravariti M, Naka KK, Kalantaridou SN, et al. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. Clin Endocrinol Metab 2005;90:5088–95
   Google Scholar
• Chowdhury UK. Histopathology and morphometry of radial artery conduits: basic study and clinical application. Ann Thorac Surg 2004;78:1614–21
   PubMed Web of Science ®Google Scholar
• Liu P, Death A, Handelsman D. Androgens and cardiovascular disease. Endocr Rev 2003;24:313–40
   PubMed Web of Science ®Google Scholar
• Pierpoint T, McKeigue PM, Isaacs AJ, et al. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 1998;51:581–6
   PubMed Web of Science ®Google Scholar
• Wild S, Pierpoint T, McKeigue PM, et al. Cardiovascular disease in women with polycystic ovary syndrome at long term follow-up: a retrospective cohort study. Clin Endocrinol 2000;52:595–600
   PubMed Web of Science ®Google Scholar
• Hillebrand U, Hausberg M, Lang D, et al. How steroid hormones act on the endothelium insights by atomic force microscopy. Pflugers Arch 2008;456:51–60
   PubMedGoogle Scholar
• Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insülin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989;38:1165–74
   PubMed Web of Science ®Google Scholar
• Yilmaz M, Biri A, Bukan N, et al. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Gynecol Endocrinol 2005;20:258–63
   PubMed Web of Science ®Google Scholar
• Welt CK, Carmina E. Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause. J Clin Endocrinol Metab 2013;98:4629–38
   PubMed Web of Science ®Google Scholar
• O’Connor A, Phelan N, Tun TK, et al. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance. J Clin Endocrinol Metab 2010;95:1378–85
   PubMed Web of Science ®Google Scholar
• Villa J, Pratley R. Adipose tissue dysfunction in polycystic ovary syndrome. Curr Diabetes Rep 2011;11:179–84
   PubMed Web of Science ®Google Scholar
• Botella-Carretero M, Benguría JI, Villuendas A, et al. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007;92:328–37
   PubMedGoogle Scholar
• Xu XF, De Pergola G, Bjorntorp P. Testosterone increases lipolysis and the number of β-adrenoceptors in male rat adipocytes. Endocrinology 1991;128:379–82
   PubMed Web of Science ®Google Scholar
• Benson S, Arck PC, Tan S, et al. Disturbed stress responses in women with polycystic ovary syndrome. Psychoneuroendocrinology 2009;34:727–35
   PubMed Web of Science ®Google Scholar
• Sverrisdóttir YB, Mogren T, Kataoka J, et al. Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? Am J Physiol Endocrinol Metab 2008;294:E576–81
   PubMed Web of Science ®Google Scholar
• Murri M, Luque-Ramırez M, Insenser M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 2013;19:268–88
   PubMed Web of Science ®Google Scholar
• Christakou C, Economou F, Livadas S, et al. Strong and positive association of endothelin-1 with AGEs in PCOS: a causal relationship or a bystander? Hormones 2011;10:292–7
   PubMedGoogle Scholar
• Christian RC, Dumesic DA, Behrenbeck T, et al. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:2562–8
   PubMed Web of Science ®Google Scholar